Administration of T cell growth factor IL-2 and PD-1/PD-L1 blockade may achieve the dual purpose of modifying the T cell exhaustion program and yield better effector T cells from TSCM cells after the transfer, resulting in complete tumor remission [73, 190]. This evidence concerns the gene IL2 and neoplasm.